Contraceptive clinical trial network contraceptive clinical trials network - female sites - evaluation of larcs STUDYHHSN275201300017I/HHSN27520003

Ended Awarded Last action

Contract number
75N94018F00003
Awardee
Awarding agency
Obligated
$639,029

Award facts

Contract value 100% obligated
$639,028.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 19 offers Multiple Award, Fair Opportunity
Pricing
Cost No Fee
Place of performance
Roxbury, MA 02118, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 $0
Other Administrative Action P00004 · Nichd: R & D: to evaluate in obese and non-obese women the pharmacokinetics and the pharmacodynamic effects, cycle control, and safety of levonorgestrel… $0
Supplemental Agreement for work within scope P00003 $122,563
Supplemental Agreement for work within scope P00002 $74,998
Supplemental Agreement for work within scope P00001 · To evaluate in obese and non-obese women the pharmacokinetics and the pharmacodynamic effects, cycle control, and safety of levonorgestrel butanoate (LB)… $177,222
Original award $264,246

About this award

This federal contract award is for the Contraceptive Clinical Trials Network - Female Sites Evaluation of LARCs Study, awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Boston Medical Center Corporation (BMC). The $639,028.72 cost-reimbursement contract has an ultimate completion date of July 14, 2026. BMC, a major safety-net hospital and academic medical center, will provide services related to the Contraceptive Clinical Trials Network, which focuses on evaluating long-acting reversible contraceptives (LARCs). The contract was not set aside. BMC holds two significant federal Indefinite Delivery Vehicles with the Centers for Disease Control and Prevention and the National Institute on Alcohol Abuse and Alcoholism, demonstrating its strategic position to support federal agencies' research and public health objectives.

Quick answers

Who was awarded contract 75N94018F00003?

75N94018F00003 was awarded to Boston Medical Center Corporation by National Institute of Child Health and Human Development (National Institutes of Health) on September 24, 2018.

How much is contract 75N94018F00003 worth?

The government has obligated $639,029 on 75N94018F00003.

Is contract 75N94018F00003 an order under another contract?

Yes. 75N94018F00003 is a delivery order under HHSN275201300017I, an indefinite delivery contract.

Was contract 75N94018F00003 competed?

The extent of competition for 75N94018F00003 was full and open competition. The government received 19 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award